These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 29746954)

  • 1. Combined IFN-γ and TNF-α release assay for differentiating active tuberculosis from latent tuberculosis infection.
    Kim JY; Park JH; Kim MC; Cha HH; Jeon NY; Park SY; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Infect; 2018 Oct; 77(4):314-320. PubMed ID: 29746954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IFN-γ and TNF-α dual release fluorospot assay for diagnosing active tuberculosis.
    Kim JY; Kang YA; Park JH; Cha HH; Jeon NY; Lee SW; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Clin Microbiol Infect; 2020 Jul; 26(7):928-934. PubMed ID: 31730906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
    PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children.
    Buonsenso D; Delogu G; Del Carmen Pereyra Boza M; De Maio F; Palucci I; Martino L; Pata D; Sanguinetti M; Valentini P; Sali M
    Eur J Pediatr; 2023 May; 182(5):2155-2167. PubMed ID: 36847873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Close contact interferon-gamma response to the new PstS1
    de Araujo LS; de Bárbara Moreira da Silva Lins N; Leung JA; Mello FC; Saad MH
    BMC Res Notes; 2017 Jan; 10(1):59. PubMed ID: 28114976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.
    Hur YG; Hong JY; Choi DH; Kim A; Park SY; Kwon M; Kang K; Lee JM; Dockrell HM; Lee Y; Joo H; Cho SN
    Yonsei Med J; 2019 Apr; 60(4):375-380. PubMed ID: 30900424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
    Tang J; Huang Y; Cai Z; Ma Y
    PLoS One; 2021; 16(7):e0254571. PubMed ID: 34270559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
    Campbell JR; Krot J; Elwood K; Cook V; Marra F
    Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cytokines for the detection of
    Nausch N; Lundtoft C; Schulz G; Henckel H; Mayatepek E; Fleischer B; Marx FM; Jacobsen M
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):270-277. PubMed ID: 28225337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
    Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
    PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
    Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
    J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Mathad JS; Bhosale R; Balasubramanian U; Kanade S; Mave V; Suryavanshi N; Gupte N; Joshi S; Chandanwale A; Dupnik KM; Kulkarni V; Deshpande P; Fitzgerald DW; Gupta A
    Am J Respir Crit Care Med; 2016 Jun; 193(12):1421-8. PubMed ID: 26765255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection.
    Lee EH; Kang YA; Leem AY; Park MS; Kim YS; Kim SK; Chang J; Kim SY
    Sci Rep; 2017 Jul; 7(1):6473. PubMed ID: 28743918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.